v3.26.1
Collaboration Agreements (Tables)
6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Revenue, Cost of Revenues, and Expense The following table summarizes the Company’s proportionate share of the activity under the Biogen Collaboration Agreement:
Three Months Ended
June 30,
Six Months Ended
June 30,
20262026
(unaudited)
(unaudited)
Collaboration revenue (ZURZUVAE)
$35,350 $62,993 
Cost of revenues
1,029 2,326 
Research and development expenses
704 1,293 
Selling, general and administrative expenses
26,457 49,909